Tested Applications
| Positive WB detected in | Jurkat cells |
| Positive IHC detected in | human stomach cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| Immunohistochemistry (IHC) | IHC : 1:250-1:1000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
13623-1-AP targets TRIM15 in WB, IHC, IF, IP, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag4533 Product name: Recombinant human TRIM15 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-270 aa of BC038585 Sequence: MPATPSLKVVHELPACTLCAGPLEDAVTIPCGHTFCRLCLPALSQMGAQSSGKILLCPLCQEEEQAETPMAPVPLGPLGETYCEEHGEKIYFFCENDAEFLCVFCREGPTHQAHTVGFLDEAIQPYRDRLRSRLEALSTERDEIEDVKCQEDQKLQVLLTQIESKKHQVETAFERLQQELEQQRCLLLARLRELEQQIWKERDEYITKVSEEVTRLGAQVKELEEKCQQPASELLQDVRVNQSRCEMKTFVSPEAISPDLVKKIRDFHRK Predict reactive species |
| Full Name | tripartite motif-containing 15 |
| Calculated Molecular Weight | 465 aa, 52 kDa |
| Observed Molecular Weight | 52 kDa |
| GenBank Accession Number | BC038585 |
| Gene Symbol | TRIM15 |
| Gene ID (NCBI) | 89870 |
| RRID | AB_2303892 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9C019 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
TRIM15 (Tripartite motif-containing protein 15) is also named as RNF93, ZNF178, ZNFB7 and belongs to the TRIM/RBCC family. It acts as an ubiquitin-protein ligase and contributes to the endogenous restriction of retroviruses in cells.
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for TRIM15 antibody 13623-1-AP | Download protocol |
| WB protocol for TRIM15 antibody 13623-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The TRIM15 Polyclonal antibody (Cat# 13623-1-AP) has 10 citations spanning journals including Nature Cell Biology, Cell Death & Disease, Cell Death Discovery, Cancer Cell International, BBA Molecular Basis of Disease, iScience, Journal of Virology, Journal of Cell Science, and Journal of Cancer. Research fields cover ERK signaling, hepatocellular carcinoma, colorectal cancer, autophagy, ovarian cancer, pancreatic cancer, lung cancer, viral/inflammatory immune signaling, and focal adhesion regulation.
| Species | Application | Title |
|---|---|---|
Nat Cell Biol TRIM15 and CYLD regulate ERK activation via lysine-63-linked polyubiquitination.
| ||
Cell Death Dis TRIM15 forms a regulatory loop with the AKT/FOXO1 axis and LASP1 to modulate the sensitivity of HCC cells to TKIs | ||
Cell Death Dis Targeting TRIM15-mediated Axin1 depolymerization suppresses Wnt signaling and inhibits colorectal cancer growth.
| ||
Cell Death Discov Trim15 stabilizes VDAC3 via ubiquitination to suppress autophagy and enhance chemosensitivity in hypopharyngeal squamous cell carcinoma.
| ||
Cancer Cell Int TRIM15 Mediates ubiquitination of Paxillin to facilitate the progression of ovarian cancer. | ||
Biochim Biophys Acta Mol Basis Dis Ubiquitin ligase TRIM15 promotes the progression of pancreatic cancer via the upregulation of the IGF2BP2-TLR4 axis |







